Elevation Oncology, Inc. (ELEV) Tops Q4 EPS by 4c

Elevation Oncology, Inc. (NASDAQ: ELEV) reported Q4 EPS of ($0.18), $0.04 better than the analyst estimate of ($0.22).

For earnings history and earnings-related data on Elevation Oncology, Inc. (ELEV) click here.

You May Also Be Interested In

• Nscale targets up to $3B in US IPO as soon as September - Bloomberg
• Raymond James sees token pricing gap widen in August 2026
• Ubiquiti (UI) Tops Q4 EPS by 25c, Beats on Revenue